Device Airway Clearance Device

Hillrom - Synclara Cough System

Payments companies reported to CMS as associated with Hillrom - Synclara Cough System. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$40Kassociated payments (2023-2025)
78clinicians with associated payments
1company reporting

By year

2023 $775
2024 $39K
2025 $788

Payments reported as associated with Hillrom - Synclara Cough System, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Pediatrics (Nurse Practitioner) $32K
Family $6,206
Pediatric Pulmonology $1,001
Pulmonary Disease $212
Internal Medicine $122
Physician Assistant $99.77

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Hillrom - Synclara Cough System

These are the largest totals companies reported as associated with Hillrom - Synclara Cough System. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Kathryn Fitzgerald New York, NY Pediatrics (Nurse Practitioner) $31,991.35
Hollie Holderfield Branson, MO Family $6,126.68
Jered Weinstock Anchorage, AK Pediatric Pulmonology $117.75
Katherine Lewinter Los Angeles, CA Pediatric Pulmonology $86.07
Jonathan Strok Orange, CA Pediatrics (Nurse Practitioner) $86.06
Emma Lind Orange, CA Pediatrics (Nurse Practitioner) $86.06
Marlene Typaldos Sanchez Houston, TX Pediatric Pulmonology $60.38
Jamie Ruderfer Neptune, NJ Pediatric Pulmonology $60.37
Adayiba Zamora Pembroke Pines, FL Acute Care (Nurse Practitioner) $44.07
Pornchai Tirakitsoontorn Orange, CA Pediatric Pulmonology $43.90

Prescribed Hillrom - Synclara Cough System?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.